Evidence map›Paper›PMID 36838882›Full record

ArticleMolecules (Basel, Switzerland)2023

Antibacterial Activity and Mechanism of Madecassic Acid against

Chunling Wei, Peiwu Cui, Xiangqian Liu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Investigating the role of cytochromeRSC medicinal chemistry · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Combinations ofAntibiotics (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Mode of Action of Antimicrobial Potential Protease SH21 Derived fromInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Potential Activities ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chunling WeiCollege of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Peiwu CuiCollege of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Xiangqian LiuCollege of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Hunan University of Traditional Chinese Medicine · CN

Funding

Graduate research project of bioengineering discipline of Hunan University of Chinese Medicine 2022SGJJ01National Natural Science Foundation of China 81973211
6 · The paper itself

Abstract

Antibacterial resistance has become one of the most serious problems threating global health. To overcome this urgent problem, many scientists have paid great attention to developing new antibacterial drugs from natural products. Hence, for exploring new antibacterial drugs from Chinese medicine, a series of experiments were carried out for verifying and elucidating the antibacterial activity and mechanisms of madecassic acid (MA), which is an active triterpenoid compound isolated from the traditional Chinese medicine,

Indexed as

Methicillin-Resistant Staphylococcus aureusTriterpenesAnti-Bacterial AgentsBacteriaEscherichia coliMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial Agentsmadecassic acidTriterpenesantibacterial activityantibacterial mechanismmadecassic acidStaphylococcus aureus

Identifiers

PMID36838882
PMCPMC9967526
OpenAlexW4321241651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.